1. Home
  2. USNA vs OCGN Comparison

USNA vs OCGN Comparison

Compare USNA & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

N/A

Current Price

$13.39

Market Cap

397.1M

Sector

Health Care

ML Signal

N/A

Logo Ocugen Inc.

OCGN

Ocugen Inc.

N/A

Current Price

$0.94

Market Cap

474.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
USNA
OCGN
Founded
1992
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.1M
474.8M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
USNA
OCGN
Price
$13.39
$0.94
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $12.17
AVG Volume (30 Days)
178.6K
★ 7.0M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,060,902,000.00
N/A
Revenue This Year
N/A
$12.33
Revenue Next Year
$3.96
$10.95
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$12.57
$0.69
52 Week High
$23.59
$2.73

Technical Indicators

Market Signals
Indicator
USNA
OCGN
Relative Strength Index (RSI) 37.78 55.68
Support Level $12.57 $0.69
Resistance Level $15.58 $1.12
Average True Range (ATR) 0.70 0.07
MACD -0.07 0.03
Stochastic Oscillator 29.49 93.31

Price Performance

Historical Comparison
USNA
OCGN

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: